Gut hormones: the future of obesity treatment?

被引：21

作者：

McGavigan, Anne K. ^{[1
]}

Murphy, Kevin G. ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Dept Invest Med, Sect Invest Med, London W12 0NN, England

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2012年 / 74卷 / 06期

基金：

英国生物技术与生命科学研究理事会;

关键词：

glucagon-like peptide-1; gut hormones; obesity; oxyntomodulin; pancreatic polypeptide; peptide YY; GLUCAGON-LIKE PEPTIDE-1; INHIBITS FOOD-INTAKE; REDUCES BODY-WEIGHT; PROOF-OF-CONCEPT; PANCREATIC-POLYPEPTIDE; RECEPTOR AGONISTS; INTRAVENOUS-INFUSION; ENERGY-INTAKE; IN-VITRO; OXYNTOMODULIN;

D O I：

10.1111/j.1365-2125.2012.04278.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Obesity is a major worldwide health problem. The treatment options are severely limited. The development of novel anti-obesity drugs is fraught with efficacy and safety issues. Consequently, several investigational anti-obesity drugs have failed to gain marketing approval in recent years. Anorectic gut hormones offer a potentially safe and viable option for the treatment of obesity. The prospective utility of gut hormones has improved drastically in recent years with the development of longer acting analogues. Additionally, specific combinations of gut hormones have been demonstrated to have additive anorectic effects. This article reviews the current stage of anti-obesity drugs in development, focusing on gut hormone-based therapies.

引用

页码：911 / 919

页数：9

共 50 条

[1] The future role of gut hormones in the treatment of obesity
Troke, Rachel C.
Tan, Tricia M.
Bloom, Steve R.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2014, 5 (01) : 4 - 14
[2] Gut hormones: Implications for the treatment of obesity
Neary, Marianne T.
Batterham, Rachel L.
PHARMACOLOGY & THERAPEUTICS, 2009, 124 (01) : 44 - 56
[3] Gut Hormones and Energy Balance, The Future for Obesity Therapy?
Meiliana, Anna
Wijaya, Andi
INDONESIAN BIOMEDICAL JOURNAL, 2009, 1 (03): : 33 - 56
[4] Gut and hormones and obesity
Wren, Alison M.
OBESITY AND METABOLISM, 2008, 36 : 165 - 181
[5] Gut hormones as therapeutic agents in treatment of diabetes and obesity
Tan, Tricia
Bloom, Stephen
CURRENT OPINION IN PHARMACOLOGY, 2013, 13 (06) : 996 - 1001
[6] Cracking the combination: Gut hormones for the treatment of obesity and diabetes
Alexiadou, Kleopatra
Anyiam, Oluwaseun
Tan, Tricia
JOURNAL OF NEUROENDOCRINOLOGY, 2019, 31 (05)
[7] Combination gut hormones: prospects and questions for the future of obesity and diabetes therapy
Khoo, Bernard
Tan, Tricia Mei-Mei
JOURNAL OF ENDOCRINOLOGY, 2020, 246 (03) : R65 - R74
[8] Obesity, gut hormones and knighthood
Bloom, Stephen R.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2013, 8 (03) : 225 - 227
[9] Role of Gut Hormones in Obesity
Jayasena, Channa N.
Bloom, Steve R.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2008, 37 (03) : 769 - +
[10] The impact of diabetes and obesity on fertility and the potential role of gut hormones as treatment
Sridhar, Ananyaa
Khan, Dawood
Moffett, R. Charlotte
DIABETIC MEDICINE, 2023, 40 (12)

← 1 2 3 4 5 →